HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors

EVAN TAN 1
Cara Sze-Hui Chin 1
Zhi Feng Sherman Lim 1
Say-Kong Ng 1
Publication typeJournal Article
Publication date2021-12-13
scimago Q1
wos Q1
SJR0.974
CiteScore8.8
Impact factor4.8
ISSN22964185
Biotechnology
Bioengineering
Histology
Biomedical Engineering
Abstract

Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more “human-like” post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.

Found 
Found 

Top-30

Journals

1
2
3
4
5
International Journal of Molecular Sciences
5 publications, 2.91%
Frontiers in Bioengineering and Biotechnology
5 publications, 2.91%
Molecular Therapy - Methods and Clinical Development
5 publications, 2.91%
Biotechnology Advances
4 publications, 2.33%
Vaccines
4 publications, 2.33%
BMC Biotechnology
3 publications, 1.74%
PLoS ONE
3 publications, 1.74%
Frontiers in Immunology
3 publications, 1.74%
ACS Omega
3 publications, 1.74%
Methods in Molecular Biology
3 publications, 1.74%
Bioengineering
2 publications, 1.16%
Biotechnology and Bioengineering
2 publications, 1.16%
Fine Chemical Technologies
2 publications, 1.16%
bioRxiv
2 publications, 1.16%
Nucleic Acids Research
2 publications, 1.16%
Antibodies
2 publications, 1.16%
Journal of Chromatography A
2 publications, 1.16%
Current Issues in Molecular Biology
2 publications, 1.16%
iScience
2 publications, 1.16%
Nature Communications
2 publications, 1.16%
Cells
2 publications, 1.16%
ACS Biomaterials Science and Engineering
2 publications, 1.16%
Advanced Science
2 publications, 1.16%
Pharmaceutics
2 publications, 1.16%
Journal of Biotechnology
2 publications, 1.16%
Cell Biochemistry and Function
1 publication, 0.58%
Sensors
1 publication, 0.58%
Virus Research
1 publication, 0.58%
Cytotherapy
1 publication, 0.58%
1
2
3
4
5

Publishers

5
10
15
20
25
30
35
40
Elsevier
39 publications, 22.67%
MDPI
30 publications, 17.44%
Springer Nature
20 publications, 11.63%
Wiley
15 publications, 8.72%
Cold Spring Harbor Laboratory
14 publications, 8.14%
Frontiers Media S.A.
10 publications, 5.81%
American Chemical Society (ACS)
8 publications, 4.65%
Public Library of Science (PLoS)
4 publications, 2.33%
Oxford University Press
4 publications, 2.33%
Pleiades Publishing
3 publications, 1.74%
RTU MIREA
2 publications, 1.16%
Royal Society of Chemistry (RSC)
2 publications, 1.16%
Research Square Platform LLC
2 publications, 1.16%
Canadian Science Publishing
1 publication, 0.58%
SAGE
1 publication, 0.58%
PeerJ
1 publication, 0.58%
Acta Naturae Ltd
1 publication, 0.58%
Academic Journals
1 publication, 0.58%
Eco-Vector LLC
1 publication, 0.58%
IntechOpen
1 publication, 0.58%
American Association for the Advancement of Science (AAAS)
1 publication, 0.58%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.58%
Mary Ann Liebert
1 publication, 0.58%
IOP Publishing
1 publication, 0.58%
The Company of Biologists
1 publication, 0.58%
Bentham Science Publishers Ltd.
1 publication, 0.58%
Federal Medical Biological Agency
1 publication, 0.58%
Hindawi Limited
1 publication, 0.58%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
173
Share
Cite this
GOST |
Cite this
GOST Copy
TAN E. et al. HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors // Frontiers in Bioengineering and Biotechnology. 2021. Vol. 9.
GOST all authors (up to 50) Copy
TAN E., Chin C. S., Lim Z. F. S., Ng S. HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors // Frontiers in Bioengineering and Biotechnology. 2021. Vol. 9.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fbioe.2021.796991
UR - https://doi.org/10.3389/fbioe.2021.796991
TI - HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
T2 - Frontiers in Bioengineering and Biotechnology
AU - TAN, EVAN
AU - Chin, Cara Sze-Hui
AU - Lim, Zhi Feng Sherman
AU - Ng, Say-Kong
PY - 2021
DA - 2021/12/13
PB - Frontiers Media S.A.
VL - 9
PMID - 34966729
SN - 2296-4185
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2021_TAN,
author = {EVAN TAN and Cara Sze-Hui Chin and Zhi Feng Sherman Lim and Say-Kong Ng},
title = {HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2021},
volume = {9},
publisher = {Frontiers Media S.A.},
month = {dec},
url = {https://doi.org/10.3389/fbioe.2021.796991},
doi = {10.3389/fbioe.2021.796991}
}